Sultana Mehebuba, Chatterjee Rudra Prasad, Kundu Sanchita, Mahmud Sk Abdul
Department of Oral and Maxillofacial Pathology, GuruNanak Institute Of Dental Science And Research, Kolkata, West Bengal, India.
J Oral Maxillofac Pathol. 2022 Apr-Jun;26(2):263-267. doi: 10.4103/jomfp.jomfp_183_21. Epub 2022 Jun 28.
Primary amelanotic malignant melanomas (AMMs) of the parotid and submandibular salivary glands are extremely rare with only a few reported cases due to its low incidence and misdiagnosis. Malignant melanoma (MM) has a high predilection for the head-and-neck region and majority of the cases in the parotid gland reported as association with metastasis in and around the gland from a cutaneous primary tumor. Immunohistochemistry is solely needed for confirmation of diagnosis and MMs give positive reactivity for melan-A, HMB-45, and S-100. Prognosis for AMM in the mucosal or salivary gland regions is much poorer than cutaneous regions because of anatomic considerations and its delayed diagnosis. The treatment of choice is radical surgery and parotidectomy along with radiotherapy and chemotherapy.
腮腺和颌下唾液腺的原发性无色素性恶性黑色素瘤极为罕见,因其发病率低且易误诊,仅有少数病例报道。恶性黑色素瘤(MM)高度好发于头颈部区域,腮腺中大多数病例报告为与皮肤原发性肿瘤转移至腮腺及其周围有关。确诊仅需免疫组织化学检查,MM对黑素A、HMB-45和S-100呈阳性反应。由于解剖学因素及诊断延迟,黏膜或唾液腺区域的无色素性恶性黑色素瘤的预后比皮肤区域差得多。首选治疗方法是根治性手术及腮腺切除术,同时辅以放疗和化疗。